Direct evidence for ultrastructures of the α-synuclein-associated synaptic vesicle pool in presynaptic terminals.

Synaptic vesicle pool Transgenic mouse α-Synuclein

Journal

Biochimica et biophysica acta. Molecular basis of disease
ISSN: 1879-260X
Titre abrégé: Biochim Biophys Acta Mol Basis Dis
Pays: Netherlands
ID NLM: 101731730

Informations de publication

Date de publication:
02 Sep 2024
Historique:
received: 16 11 2023
revised: 06 08 2024
accepted: 27 08 2024
medline: 5 9 2024
pubmed: 5 9 2024
entrez: 5 9 2024
Statut: aheadofprint

Résumé

SNCA/PARK1 encodes α-synuclein, which is associated with familial Parkinson's disease. Despite its abundance in presynaptic terminals, the aggregation mechanism of α-synuclein and its relationship with Parkinson's disease have not yet been elucidated. Moreover, the ultrastructures of α-synuclein localization sites in neuronal presynaptic terminals remain unclear. Therefore, we herein generated transgenic mice expressing human α-synuclein tagged with mKate2 (hSNCA-mKate2 mice). These mice exhibited normal growth and fertility and had no motor dysfunction relative to their wild-type littermates, even at one year old. α-Synuclein-mKate2 accumulated in presynaptic terminals, particularly between Purkinje cells in the cerebellum and neurons in cerebellar nuclei. α-Synuclein-mKate2 was associated with the presynaptic marker, synaptophysin. In-resin CLEM and immunoelectron or electron microscopy revealed that α-synuclein-mKate2 localized on the surface of synaptic vesicles that were tightly arranged and assembled to form large synaptic pools in the cerebellum with negligible effects on the active zone. These results suggest that α-synuclein-associated ultrastructures in the presynaptic terminals of hSNCA-mKate2 mice reflect the structures of α-synuclein-assembled synaptic vesicle pools, and the size of vesicle pools increased. This transgenic mouse model will be a valuable tool for studying α-synuclein-associated synaptic vesicle pools.

Identifiants

pubmed: 39233262
pii: S0925-4439(24)00488-5
doi: 10.1016/j.bbadis.2024.167494
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

167494

Informations de copyright

Copyright © 2024. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of competing interest None declared

Auteurs

Chigure Suzuki (C)

Department of Cellular and Molecular Neuropathology, Research Institute for Old Age, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo 113-8421, Japan; Department of Cellular and Molecular Pharmacology, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo 113-8421, Japan; Juntendo University Center for Diversity and Inclusion, Bunkyo-ku, Tokyo 113-8421, Japan.

Junji Yamaguchi (J)

Department of Cellular and Molecular Neuropathology, Research Institute for Old Age, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo 113-8421, Japan; Laboratory of Morphology and Image Analysis, Biomedical Research Center, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo 113-8421, Japan.

Shun Mitsui (S)

Department of Cellular and Molecular Neuropathology, Research Institute for Old Age, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo 113-8421, Japan.

Takahito Sanada (T)

Department of Cellular and Molecular Neuropathology, Research Institute for Old Age, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo 113-8421, Japan.

Juan Alejandro Oliva Trejo (JAO)

Department of Cellular and Molecular Neuropathology, Research Institute for Old Age, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo 113-8421, Japan.

Soichirou Kakuta (S)

Department of Cellular and Molecular Neuropathology, Research Institute for Old Age, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo 113-8421, Japan; Laboratory of Morphology and Image Analysis, Biomedical Research Center, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo 113-8421, Japan.

Kenichi Tanaka (K)

Department of Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, 2-4-41 Ebara, Shinagawa-ku, Tokyo 142-8501, Japan; Division of Cancer Pathophysiology, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.

Yukari Suda (Y)

Department of Pharmacology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, 2-4-41 Ebara, Shinagawa-ku, Tokyo 142-8501, Japan; Division of Cancer Pathophysiology, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.

Taku Hatano (T)

Department of Neurology, Juntendo University Graduate School of Medicine, Bunkyo-Ku, Tokyo 113-8421, Japan.

Nobutaka Hattori (N)

Department of Neurology, Juntendo University Graduate School of Medicine, Bunkyo-Ku, Tokyo 113-8421, Japan.

Isei Tanida (I)

Department of Cellular and Molecular Neuropathology, Research Institute for Old Age, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo 113-8421, Japan. Electronic address: tanida@juntendo.ac.jp.

Yasuo Uchiyama (Y)

Department of Cellular and Molecular Neuropathology, Research Institute for Old Age, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo 113-8421, Japan; Department of Drug Discovery Research for Synucleopathies, Juntendo University Graduate School of Medicine, Bunkyo-Ku, Tokyo 113-8421, Japan. Electronic address: y-uchi@juntendo.ac.jp.

Classifications MeSH